Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2015 Mar;20(3):e3-4.
doi: 10.1634/theoncologist.2014-0415.

Challenges of efficacy assessments in pseudomyxoma peritonea

Michael J Overman  1 , Cathy Eng  1 , Kanwal Raghav  1 , Aurelio Matamoros  2 , Melissa Taggart  3 , Wai Chin Foo  3 , Keith Fournier  4
Affiliations
Comment

Challenges of efficacy assessments in pseudomyxoma peritonea

Michael J Overman et al. Oncologist. 2015 Mar.

Abstract

Several critical issues need to be considered in interpreting the results of the single-center observational study of the FOLFOX regimen in appendiceal pseudomyxoma peritonei reported by Pietrantonio et al.

PubMed Disclaimer

Comment in

  • In reply.
    Baratti D, Kusamura S, Maggi C, de Braud F, Deraco M, Di Bartolomeo M, Pietrantonio F. Baratti D, et al. Oncologist. 2015 Mar;20(3):e5. doi: 10.1634/theoncologist.2014-423. Oncologist. 2015. PMID: 25745055 Free PMC article.

Comment on

  • FOLFOX-4 chemotherapy for patients with unresectable or relapsed peritoneal pseudomyxoma.
    Pietrantonio F, Maggi C, Fanetti G, Iacovelli R, Di Bartolomeo M, Ricchini F, Deraco M, Perrone F, Baratti D, Kusamura S, Tamborini E, Castano A, Consonni PV, Bossi I, Gavazzi C, Milione M, Pelosi G, de Braud F. Pietrantonio F, et al. Oncologist. 2014 Aug;19(8):845-50. doi: 10.1634/theoncologist.2014-0106. Epub 2014 Jun 20. Oncologist. 2014. PMID: 24951608 Free PMC article.

References

    1. Pietrantonio F, Maggi C, Fanetti G, et al. FOLFOX-4 chemotherapy for patients with unresectable or relapsed peritoneal pseudomyxoma. The Oncologist. 2014;19:845–850. - PMC - PubMed
    1. Overman MJ, Fournier K, Hu CY, et al. Improving the AJCC/TNM staging for adenocarcinomas of the appendix: The prognostic impact of histological grade. Ann Surg. 2013;257:1072–1078. - PMC - PubMed
    1. Ronnett BM, Zahn CM, Kurman RJ, et al. Disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis. A clinicopathologic analysis of 109 cases with emphasis on distinguishing pathologic features, site of origin, prognosis, and relationship to “pseudomyxoma peritonei”. Am J Surg Pathol. 1995;19:1390–1408. - PubMed
    1. Bradley RF, Stewart JH, IV, Russell GB, et al. Pseudomyxoma peritonei of appendiceal origin: A clinicopathologic analysis of 101 patients uniformly treated at a single institution, with literature review. Am J Surg Pathol. 2006;30:551–559. - PubMed
    1. Misdraji J, Yantiss RK, Graeme-Cook FM, et al. Appendiceal mucinous neoplasms: A clinicopathologic analysis of 107 cases. Am J Surg Pathol. 2003;27:1089–1103. - PubMed

MeSH terms